Texas Oncology - Dallas Presbyterian Hospital is a clinical research site located in Dallas, Texas, United States 75231.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology - Dallas Presbyterian Hospital has participated in 17 clinical trials with 7 currently active.
Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Colorectal Cancer.
Sponsors: Greenwich LifeSciences, Inc., Eli Lilly and Company, HiberCell, Inc..
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - Dallas Presbyterian Hospital has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - Dallas Presbyterian Hospital has 17 clinical trials on record, with 7 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Colorectal Cancer.
Yes — Texas Oncology - Dallas Presbyterian Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.